Login / Signup

Microphysiological model reveals the promise of memory-like natural killer cell immunotherapy for HIV ± cancer.

Jose Maria Ayuso DominguezMehtab FarooquiMaría Virumbrales-MuñozKatheryn DeneckeShujah RehmanRebecca SchmitzJorge F GuerreroCristina Sanchez-de-DiegoSara Abizanda CampoElizabeth M MalyMatthew H ForsbergSheena C KerrRobert StrikerNathan M ShererPaul HarariChristian M CapitiniMelissa C SkalaDavid J Beebe
Published in: Nature communications (2023)
Numerous studies are exploring the use of cell adoptive therapies to treat hematological malignancies as well as solid tumors. However, there are numerous factors that dampen the immune response, including viruses like human immunodeficiency virus. In this study, we leverage human-derived microphysiological models to reverse-engineer the HIV-immune system interaction and evaluate the potential of memory-like natural killer cells for HIV + head and neck cancer, one of the most common tumors in patients living with human immunodeficiency virus. Here, we evaluate multiple aspects of the memory-like natural killer cell response in human-derived bioengineered environments, including immune cell extravasation, tumor penetration, tumor killing, T cell dependence, virus suppression, and compatibility with retroviral medication. Overall, these results suggest that memory-like natural killer cells are capable of operating without T cell assistance and could simultaneously destroy head and neck cancer cells as well as reduce viral latency.
Keyphrases